Zentrum fᅢテᅡᄐr Labormedizin Revenue and Competitors
Estimated Revenue & Valuation
- Zentrum fᅢテᅡᄐr Labormedizin's estimated annual revenue is currently $27.8M per year.
- Zentrum fᅢテᅡᄐr Labormedizin's estimated revenue per employee is $270,000
Employee Data
- Zentrum fᅢテᅡᄐr Labormedizin has 103 Employees.
- Zentrum fᅢテᅡᄐr Labormedizin grew their employee count by 6% last year.
Zentrum fᅢテᅡᄐr Labormedizin's People
Name | Title | Email/Phone |
---|
Zentrum fᅢテᅡᄐr Labormedizin Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $214.3M | 635 | 1% | N/A | N/A |
#2 | $199.1M | 590 | 5% | N/A | N/A |
#3 | $49.9M | 168 | 37% | N/A | N/A |
#4 | $20.5M | 76 | 7% | N/A | N/A |
#5 | $27.8M | 103 | 6% | N/A | N/A |
#6 | $104M | 308 | 7% | N/A | N/A |
#7 | $49.3M | 166 | 7% | N/A | N/A |
#8 | $403.3M | 1067 | 11% | N/A | N/A |
#9 | $44M | 148 | 20% | N/A | N/A |
#10 | $4.7M | 25 | 9% | N/A | N/A |
What Is Zentrum fᅢテᅡᄐr Labormedizin?
Das ZLM St. Gallen gehᅢテᅡᄊrt zu den fᅢテᅡᄐhrenden medizinisch-diagnostischen Laboratorien der Schweiz. Unsere rund 200 Mitarbeiterinnen und Mitarbeiter fᅢテᅡᄐhren Routine- und Spezialanalysen in der Klinischen Chemie, Hᅢテᅡᄂmatologie, Hᅢテᅡᄂmostaseologie, Mikrobiologie, Immunologie, Molekularbiologie, Genetik und Veterinᅢテᅡᄂrdiagnostik durch. Zu unseren Auftraggebern zᅢテᅡᄂhlen das Kantonsspital St. Gallen, die Spitalregion Rheintal Werdenberg Sarganserland, sowie die anderen Spitᅢテᅡᄂler des Kantons St. Gallen, niedergelassene ᅢテ¬ダrztinnen und ᅢテ¬ダrzte, nationale und internationale Spitᅢテᅡᄂler und Universitᅢテᅡᄂten. Unsere Labordiagnostik ist hochgradig automatisiert und vernetzt.
keywords:N/AN/A
Total Funding
103
Number of Employees
$27.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $42.4M | 120 | 5% | N/A |
#2 | N/A | 161 | 9% | N/A |
#3 | $37.4M | 243 | 51% | N/A |
#4 | N/A | 284 | 51% | N/A |
#5 | N/A | 284 | 51% | N/A |